AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,604,019 | +35.3% | 194,649 | +39.1% | 0.00% | 0.0% |
| Q2 2023 | $10,056,017 | -39.5% | 139,939 | -48.0% | 0.00% | -50.0% |
| Q1 2023 | $16,611,657 | -24.7% | 269,320 | -5.8% | 0.00% | -20.0% |
| Q4 2022 | $22,062,188 | -4.8% | 286,039 | -44.9% | 0.01% | 0.0% |
| Q3 2022 | $23,170,000 | +60.3% | 519,264 | +37.6% | 0.01% | +66.7% |
| Q2 2022 | $14,452,000 | +500.7% | 377,337 | +549.0% | 0.00% | +200.0% |
| Q1 2022 | $2,406,000 | -20.4% | 58,137 | -27.4% | 0.00% | 0.0% |
| Q4 2021 | $3,024,000 | +110.0% | 80,050 | +83.1% | 0.00% | – |
| Q3 2021 | $1,440,000 | -49.2% | 43,709 | +4.0% | 0.00% | -100.0% |
| Q2 2021 | $2,835,000 | -64.9% | 42,028 | -70.5% | 0.00% | -50.0% |
| Q1 2021 | $8,079,000 | -49.9% | 142,690 | -27.9% | 0.00% | -50.0% |
| Q4 2020 | $16,114,000 | -31.6% | 197,796 | -40.1% | 0.00% | -42.9% |
| Q3 2020 | $23,545,000 | -31.2% | 330,457 | -20.6% | 0.01% | -30.0% |
| Q2 2020 | $34,246,000 | +136.9% | 416,210 | +69.4% | 0.01% | +100.0% |
| Q1 2020 | $14,455,000 | -31.4% | 245,707 | +20.6% | 0.01% | 0.0% |
| Q4 2019 | $21,066,000 | +3342.2% | 203,808 | +574.4% | 0.01% | – |
| Q3 2019 | $612,000 | +8.1% | 30,220 | +37.4% | 0.00% | – |
| Q2 2019 | $566,000 | -41.5% | 21,992 | -67.7% | 0.00% | – |
| Q1 2019 | $968,000 | +306.7% | 68,053 | +60.2% | 0.00% | – |
| Q4 2017 | $238,000 | -36.0% | 42,473 | -37.2% | 0.00% | – |
| Q2 2017 | $372,000 | +207.4% | 67,618 | +118.7% | 0.00% | – |
| Q1 2017 | $121,000 | -10.4% | 30,920 | +73.2% | 0.00% | – |
| Q2 2016 | $135,000 | -40.3% | 17,854 | -26.9% | 0.00% | – |
| Q4 2015 | $226,000 | – | 24,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |